Inflammation response of epithelial mucosa to chemo-radiotherapy cytotoxic effects leads to
mucositis, a painful side effect of antineoplastic treatments. About 40% of the patients treated …

Allergists and clinical immunologists around the world are increasingly faced with the task of
addressing drug allergy and hypersensitivity due to the increase in drug reactions …

Despite the enthusiasm surrounding novel targeted agents and immunotherapies,
chemotherapy remains the mainstay treatment for most human malignancies, either alone or …

Mucositis is a common complication of chemotherapy, radiotherapy and targeted agents. It
often affects compliance to anticancer therapies as it frequently causes schedule delays …

Oral and gastrointestinal mucositis caused by high-dose chemotherapy and/or radiation
continues to be an important clinical problem. Fortunately, there have been strategic …

Background: Chemoradiotherapy-associated mucositis can manifest as pain, inflammation,
dysphagia, diarrhea, weight loss, rectal bleeding, and infection. Mucositis is a major dose …

Oral mucositis induced by conventional cytotoxic cancer therapies is a common and
significant clinical problem in oncology. Mucositis symptoms, which include severe pain …

Abstract Development of biological targeted therapies and immune checkpoint inhibitors has
redefined the treatment for many cancers; however, the increasing use of new protocols has …

Mucositis is a major side effect induced by chemotherapy and radiotherapy. Although
mucositis is a leading cause of morbidity and mortality in cancer patients, management is …

Oral complications of cancer treatment are common; however, their clinical and economic
importance is often underappreciated. We reviewed the literature on the economic …